09/02/2026
New hope for PTSD is on the horizon. The Texas A&M Institute of Biosciences and Technology and healthcare tech company Wave Neuroscience teamed up to create a personalized brain therapy that’s now FDA-cleared, offering lasting relief.
Unlike traditional treatments that don’t work for everyone, this breakthrough technology targets the unique brain patterns linked to PTSD and delivers four times greater symptom improvement, with remission rates reaching 68%.
This treatment is not just a milestone for science, but an indication that healing could be possible for the millions struggling every day.
Read more about this exciting breakthrough ⤵️
FacebookTweet Approximately 17.5 veterans die by su***de every day in the United States, and 7% of veterans are diagnosed each year with post-traumatic stress disorder (PTSD). Against that backdrop, Texas A&M Health researchers are helping to advance a more personalized approach to treating the diso...